Yahoo!   My Yahoo!   Mail  
Search   
Sign In
New User? Sign Up
Home > Investing > GHDX > Summary

Genomic Health Inc.
(GHDX)

17.18USD   Up0.24 (1.42%)   
At 2:30AM IST
 Genomic Health Inc. (NGM:GHDX) Delayed quote data 
[Chart]
1d  5d  3m  6m  1y  2y  5y 
Last Trade: 17.18USD
Trade Time:2:30AM IST
Change:Up0.24 (1.42%)
Prev Close:16.94
Open:16.99
Bid:16.42 x 100
Ask:N/A
1y Target Est:21.75
Day's Range:16.80 - 17.32
52wk Range:15.81 - 27.22
Volume:105,426
Avg Vol (3m):171,692
Market Cap:491.97M
P/E (ttm):N/A
EPS (ttm):-0.40
Div & Yield:N/A (N/A%)
Add GHDX to Portfolio   Download Data

HEADLINES

 
•New Star Analyst Rankings for Genomic Health, Inc. - StarMine  - Thu, Feb 4
•GENOMIC HEALTH INC Files SEC form 8-K, Results of Operations and Financial Condition, Other Events - EDGAR Online  - Thu, Feb 4
•Genomic Health Announces Year-End 2009 Financial Results - PR Newswire  - Thu, Feb 4
•Q4 2009 Genomic Health, Inc. Earnings Release - After Market Close - CCBN  - Wed, Feb 3
•Genomic Health to Announce Fourth Quarter and Year-End 2009 Financial Results and Host Conference Call on Wednesday, February 3 - PR Newswire  - Wed, Jan 27
•5 Diagnostics Stocks Get 2010 Buy Rating From Natixis Bleichroeder Expert Industry Analyst - Wall Street Transcript  - Mon, Jan 25
•Gene discovery may help guide breast cancer care - Reuters  - Sun, Jan 24
•Good News from Genomic Health - Zacks.com  - Sat, Jan 23
•Genomic Health upgraded by Piper Jaffray - Briefing.com  - Fri, Jan 22
•Genomic Health Announces Worldwide Availability of the Oncotype DX(R) Colon Cancer Test - PR Newswire  - Thu, Jan 21
•Genomic Health Announces Publication of Data Demonstrating that the Oncotype DX(R) Breast Cancer Test Significantly Influences Breast Cancer Treatment Decisions, While Increasing Physician Confidence and Patient Satisfaction - PR Newswire  - Tue, Jan 12
» More Headlines for GHDX...

ANALYST

 
EPS Est (next year) (Dec-09) :-0.37
EPS Est (in 2 years) (Dec-10) :0.10
Avg Rec (current)*:2.6
PEG Ratio:N/A
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
» Analyst Opinion» Estimates

BUSINESS SUMMARY

 
Genomic Health, Inc. operates as a life science company focused on the development and commercialization of genomic-based clinical laboratory services for cancer that allow physicians and patients to make individualized treatment decisions.

» Full Company Profile